Cannabis Market Size

The global cannabis market has witnessed significant growth, valued at USD 41.95 billion in 2024 and projected to reach USD 290.73 billion by 2033. This represents a robust CAGR of 24% during the forecast period from 2025 to 2033. The rising global acceptance of cannabis is driven primarily by its numerous medical benefits, particularly in chronic pain relief. Additionally, the increasing popularity of Cannabidiol (CBD) in skincare products is helping elevate its status, offering solutions for skin hydration and conditions such as eczema.

Cannabis, encompassing several flowering plant species, has been utilized for millennia due to its recognized therapeutic and medicinal properties. The predominant species include C. Sativa, C. Indica, and C. Ruderalis, with current cultivars being predominantly hybrids. This evolving landscape is set to expand further as more countries embrace legalization, particularly for medical applications.

Cannabis Market Growth Factors

Increasing Legalization of Cannabis

The push for greater legalization marks a transformative phase for the cannabis industry. As medical benefits become clearer, particularly in pain management, countries worldwide are beginning to adopt more favorable policies regarding cannabis use.

• Examples of Legalization: Following Uruguay’s pioneering steps, Canada legalized cannabis for recreational use in 2018. The Drug Policy Alliance reports that Mexico anticipated similar regulations in 2019, while nations such as Colombia and Argentina have also legalized medical weed or decriminalized personal usage. Conversely, Brazil remains hesitant about going beyond medical allowances.

In the United States, 11 states and Washington, D.C., have legalized recreational marijuana, with 30 states approving its use for medical purposes. This trend is likely to continue, fueled by a growing understanding of cannabis’s therapeutic benefits.

In Asia, Thailand took a significant step in December 2018 by legalizing medical marijuana. However, despite some regional innovations, widespread legalization is still a distant goal in countries like India, presenting a hindrance to market growth in the Asia-Pacific region.

The Rising Popularity of Cannabidiol in Skincare

The integration of CBD in skincare products—such as CBD Body Oil and CBD Face Cream—is burgeoning. These products are celebrated not just for hydration but also for their potential to alleviate skin issues like eczema, thus opening vast opportunities for the skincare sector.

• Market Players: Industry giants such as L’Oréal and Estee Lauder have already ventured into the CBD skincare market, although the lack of robust clinical research poses challenges regarding efficacy and dosing. Despite that uncertainty, the demand for CBD-infused products continues to surge, encouraging independent brands to thrive within this lucrative, traditionally luxury-dominated space.

Restraining Factors

Lack of Access to Financial Assistance

Banking remains a significant hurdle for the cannabis industry, predominantly due to its legal status. As cannabis remains illegal under federal law in many countries, banks often hesitate to offer their services to businesses associated with the sector. This difficulty extends to ancillary services, such as landlords and consultants, making it challenging for anyone linked to the industry to secure traditional banking amenities.

In the U.S., despite state-level legalization for medical and recreational use, federal law classifies cannabis as a Schedule I substance, alongside drugs like heroin. This legal ambiguity means most financial institutions—Visa and Mastercard included—remain reluctant to engage with cannabis businesses.

Additionally, banks that do serve cannabis enterprises often impose exorbitant fees. For instance, Maryland’s Severn Bancorp charges clients as much as USD 3,000 to open an account, coupled with steep monthly fees of USD 1,750. The lack of accessible banking services not only endangers financial security but also stifles market growth.

Market Opportunity

Growing Focus on the Health Benefits of Cannabis

One of cannabis’s most appealing aspects is its chemical diversity, particularly cannabinoids, some of which have become crucial in medical therapies. For example, cannabis-derived products are increasingly being investigated for their roles in managing chronic pain, diabetes, and even preventing certain eye diseases like glaucoma, which can lead to vision loss.

Recent research spearheaded by the American Alliance for Medical Cannabis (AAMC) suggests that cannabis may stabilize blood sugar levels, reduce blood pressure, and improve circulation. As public awareness of these health benefits continues to rise, the demand for cannabis and its by-products is expected to increase significantly.

Regional Insights

North America: Dominant Region with a CAGR of 14.5%

North America dominates the cannabis market, projected to experience a CAGR of 14.5% during the forecast period. Notably, the U.S. has accepted recreational and therapeutic cannabis more broadly. By 2020, 15 states and two territories had legalized recreational use, while 35 states and four territories permitted medical applications. Major players in the American market, such as CV Sciences, are intensifying their focus on hemp-derived phytocannabinoids across various industry sectors.

South America: Fastest-Growing Region

South America displays promise, estimated to reach an expected market value of USD 18 billion by 2030, growing at a CAGR of 13.9%. Argentina is making strides with a legal framework around medical marijuana, having legalized the use of marijuana oils in 2017 while still prohibiting personal cultivation.

The trend appears positive as more South American nations re-evaluate cannabis regulations, creating opportunities for corporate alliances and market expansion.

Europe, while trailing behind North America and South America, is also a growing market, particularly as Germany has authorized medical marijuana to address rising patient demands. The country’s health regulations are gradually evolving, with significant imports of therapeutic products indicating a burgeoning market.

Cannabis Market Segmentation Analysis

By Product Type

The concentrates segment has emerged as a leader in the cannabis market, projected to register a CAGR of 15% during the forecast period. Marijuana concentrates, which primarily contain tetrahydrocannabinol (THC), are undergoing a surge in popularity as consumers seek a range of consumption methods.

Edibles represent the second-largest segment, with an array of products available—from gummies to chocolates—geared toward both recreational and medicinal uses. Major brands like Diamond CBD and Kiva are capitalizing on this trend.

By Application

The recreational segment leads the market with an expected CAGR of 14.7%. As demand swells, companies are investing heavily in research and development to innovate product delivery systems and optimize strains. The medical segment is also experiencing growth, with countries worldwide approving cannabis for various therapeutic use cases—a trend that appears set to continue.

By Compound Type

The THC segment dominates the market, estimated to achieve a CAGR of 15.1% as companies develop high-yielding cannabis varieties with improved quality and lower THC content for both medical and industrial applications. The EU now recognizes low-THC cannabis as an agricultural commodity, further encouraging cultivation efforts.

List of Key Players in the Cannabis Market

• Tilray
• Canopy Growth Corp
• GW Pharmaceuticals PLC
• Aurora Cannabis Inc.
• Aphria Inc.
• MedReLeaf Corp
• CV Sciences Inc.
• Delta 9 Cannabis
• Cannimed Therapeutics Inc.
• Vivo Cannabis
• Good Leaf
• Halo Labs

Recent Developments

• November 2022: BioSteel Sports Nutrition announced a partnership with elite hockey players for product endorsement.
• October 2022: Canopy Growth Corporation is set to establish a U.S.-domiciled holding company to enhance its U.S. cannabis market entry.

Cannabis Market Report Scope

For more details about trends and opportunities in the cannabis sector, download our report.